EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy

Leandro Sierra, Clive J Miranda, Maria O Abad, Butros Fakhoury, Maria Saavedra-Martinez, Ahmed Al-Hindawi, Eyad Abdulrazzak, Pojsakorn Danpanichkul, Tzu-Hao Lee, Nikki Duong, Sandeep Mukherjee

HPB · 2026-07 · 28 (7) · 877-888

DOI: 10.1016/j.hpb.2026.03.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2026-07. Verfasst von Leandro Sierra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. Electronic address: sierral@ccf.org. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Cholangiocarcinoma, Liver Neoplasms. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCarcinoma, HepatocellularCholangiocarcinomaLiver NeoplasmsBile Duct NeoplasmsHumansUnited StatesFemaleWaiting ListsRegistriesMaleMiddle AgedTreatment OutcomeTime FactorsGraft SurvivalRisk FactorsAged

Stichwörter der Autor:innen

Combined hepatocellular-cholangiocarcinomaLiver transplantationPost-transplant survivalPrimary liver malignancyWaitlist outcomes

Autor:innen und Institutionen

  • Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. Electronic address: sierral@ccf.org.
  • Department of Gastroenterology, Creighton University School of Medicine, Omaha, NE, USA.
  • Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Facultad de Medicina, Universidad de La Sabana, Chía, Colombia.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Zitieren

APA

Sierra, L., Miranda, C. J., Abad, M. O., Fakhoury, B., Saavedra-Martinez, M., Al-Hindawi, A., Abdulrazzak, E., Danpanichkul, P., Lee, T. H., Duong, N., & Mukherjee, S. (2026). Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy. HPB, 28(7), 877-888. https://doi.org/10.1016/j.hpb.2026.03.010

Vancouver

Sierra L, Miranda CJ, Abad MO, Fakhoury B, Saavedra-Martinez M, Al-Hindawi A, et al. Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy. HPB. 2026;28(7):877-888. doi:10.1016/j.hpb.2026.03.010

BibTeX
@article{Sierra2026,
  author = {Sierra, Leandro and Miranda, Clive J and Abad, Maria O and Fakhoury, Butros and Saavedra-Martinez, Maria and Al-Hindawi, Ahmed and Abdulrazzak, Eyad and Danpanichkul, Pojsakorn and Lee, Tzu-Hao and Duong, Nikki and Mukherjee, Sandeep},
  title = {Liver transplant for combined hepatocellular-cholangiocarcinoma: United States outcomes and influence of the MMaT-3 policy},
  journal = {HPB},
  year = {2026},
  volume = {28},
  number = {7},
  pages = {877--888},
  doi = {10.1016/j.hpb.2026.03.010}
}
Kostenlos starten →